Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

narmac

Jan 31, 2022 09:10AM

fouremm

Rank: President [?]

Points: 3330 [?]

Votes: 34 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

in response to

Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

narmac

posted on Jan 31, 2022 11:03AM

JMO, but from a business perspective just replacing one also ran with another also ran. Without doing an exhaustive search Brad Thompson's biggest "claim to fame" has been Oncolytics which is another (sadly) Calgary based biotech that has been a regular capital sinkhole.

5 Recommendations

Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

KOO-KOO2

Feb 01, 2022 07:45AM

Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

Toinv

Feb 07, 2022 12:27PM

Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

fuzzyjr

Feb 07, 2022 12:37PM

Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

fouremm